Gut microbiota-derived butyrate ameliorates pediatric IgA vasculitis via GPR43 by inhibiting the NF-κB/NLRP3 inflammatory cascade and attenuating Tfh17-driven IgA production
Immunoglobulin A vasculitis (IgAV) is the most common pediatric systemic small-vessel vasculitis, with renal involvement directly determining long-term prognosis; yet no etiology-targeted interventions are clinically available. Butyrate, a gut microbiota-derived metabolite that regulates mucosal immune homeostasis, has unclear mechanisms underlying its effects on IgAV-associated multiorgan damage. Here we show that butyrate-producing microbiota are specifically depleted in children with active IgAV. Among seven major short-chain fatty acids, only butyrate is significantly decreased and tends to be negatively correlated with disease activity and renal injury indices. Using an ovalbumin-induced IgAV rat model, we demonstrate that sodium butyrate and Clostridium butyricum both reduce IgA immune complex deposition and multi-organ inflammatory infiltration via GPR43, synergistically repairing the intestinal barrier, suppressing NF-κB/NLRP3 activation and IL-6/STAT3-dependent Tfh17 differentiation, and inhibiting aberrant IgA production. These findings reveal a gut dysbiosis–butyrate deficiency–IgAV pathogenesis cascade, supporting butyrate-based preparations as a promising etiology-targeted intervention for IgAV.
Authors
- Jinhai Ma
- Zhijia Yan
- Ting Ma (ORCID: https://orcid.org/0000-0002-1814-7997)
- Yujing Gu (ORCID: https://orcid.org/0009-0001-4106-0048)
- Xiaolong Ma
- Hao Wang
- Xiaoxia Zhang
- Jiahui Wang
Institutions
- Ningxia Medical University (CN)
- Ningxia Medical University General Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11101186/v1
- Primary Topic
- Gut microbiota and health
- Type
- preprint